The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase III, two-arm trial of paclitaxel, carboplatin, and maintenance letrozole versus letrozole monotherapy in patients with stage II-IV, primary low-grade serous carcinoma of the ovary or peritoneum.
 
Amanda Nickles Fader
Honoraria - Eisai; Ethicon; Intuitive Surgical; Merck; Mersana
Consulting or Advisory Role - Merck
 
Lilian Tran Gien
No Relationships to Disclose
 
Austin Miller
(OPTIONAL) Uncompensated Relationships - Genetect
 
Al Covens
No Relationships to Disclose
 
David Marc Gershenson
Stock and Other Ownership Interests - Biogin; Bristol-Myers Squibb; Johnson & Johnson
Consulting or Advisory Role - Genentech
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Royalties from Elsevier as book editor; Royalties from UpToDate for authorship